Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label Treatment Extension Study

ClinicalTrials.gov ID: NCT02896296

Public ClinicalTrials.gov record NCT02896296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study is to provide ongoing treatment with RBP-6000 and safety monitoring for subjects who complete the RB-US-13-0003 study (NCT02510014) and for whom a new treatment venue has not been identified or arranged.

Study identification

NCT ID
NCT02896296
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Indivior Inc.
Industry
Enrollment
208 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 17, 2016 (Actual)
Primary completion
Aug 23, 2017 (Actual)
Completion
Aug 23, 2017 (Actual)
Last update posted
Nov 29, 2018

2016 – 2017

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Boyett Health Services Hamilton Alabama 35570 —
Woodland International Research Group Little Rock Arkansas 72211 —
Collaborative Neuroscience Network Long Beach California 90806 —
Pacific Research Partners Oakland California 94612 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Amit Vijapura Jacksonville Florida 32256 —
Meridien Research Lakeland Florida 33805 —
Innovative Clinical Research Lauderhill Florida 33319 —
Scientific Clinical Research North Miami Florida 33161 —
Phoenix Medical Research Prairie Village Kansas 66206 —
Louisiana Research Associates New Orleans Louisiana 70114 —
Louisiana Clinical Research Shreveport Louisiana 71101 —
Stanley Street Treatment and Resources Fall River Massachusetts 02720 —
Adams Clinical Trials Watertown Massachusetts 02472 —
Precise Research Centers, Inc. Flowood Mississippi 39232 —
St Louis Clinical Trials St Louis Missouri 63141 —
Altea Research Las Vegas Nevada 89102 —
Hassman Research Institute Berlin New Jersey 08009 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
Neuro-behavioral Clinical Research Canton Ohio 44708 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Rakesh Ranjan MD & Associates, Inc. Garfield Heights Ohio 44125 —
Pahl Pharmaceutical Professionals Oklahoma City Oklahoma 73112 —
SP Research, PLLC Oklahoma City Oklahoma 73112 —
CODA Portland Oregon 97232 —
Keystone Clinical Solutions Altoona Pennsylvania 16601 —
Carolina Clinical Trials Charleston South Carolina 29407 —
Pillar Clinical Research Dallas Texas 75243 —
InSite Clinical Research DeSoto Texas 75115 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02896296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2018 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02896296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →